03 Jun 2021

Investing with impact: BMO Sustainable Opportunities European Equity Strategy

During 2020, 82% of our ESG activity positively aligned to the UN Sustainable Development Goals with a focus on SDG 3 – Good Health and Well-being. One of our ESG highlights includes engaging with Covid-19 vaccine developer AstraZeneca, and Swedish firm Elekta, which specialises in radiotherapy equipment for cancer treatment. Discover more by downloading our latest impact report for our BMO Sustainable Opportunities European Equity Strategy

 

VIEW REPORT


Share this article